Urolithiasis Management Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Treatment Type (Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy, Others), By End Use (Hospitals & Clinics, Ambulatory Surgical Centers, Others), By Region, and By Competition, 2019-2029F
Published Date: November - 2024 | Publisher: MIR | No of Pages: 320 | Industry: Healthcare | Format: Report available in PDF / Excel Format
View Details Buy Now 2890 Download Sample Ask for Discount Request CustomizationUrolithiasis Management Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Treatment Type (Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy, Others), By End Use (Hospitals & Clinics, Ambulatory Surgical Centers, Others), By Region, and By Competition, 2019-2029F
| Forecast Period | 2025-2029 |
| Market Size (2023) | USD 1.53 billion |
| Market Size (2029) | USD 1.97 Billion |
| CAGR (2024-2029) | 4.77% |
| Fastest Growing Segment | Intracorporeal Lithotripsy |
| Largest Market | North America |
Market Overview
Global Urolithiasis Management Devices Market was valued at USD 1.53 billion in 2023 and is anticipated to project steady growth in the forecast period with a CAGR of 4.77% through 2029. Due to various factors, there
Key Market Drivers
Increasing Prevalence of Urolithiasis
Urolithiasis, commonly known as kidney stones, has emerged as a prevalent and escalating health concern, impacting millions of individuals worldwide. As the incidence of this painful condition continues to rise, so does the demand for cutting-edge urolithiasis management devices.
The healthcare industry has witnessed remarkable advancements in the field of urology. These innovations have given rise to an array of sophisticated urolithiasis management devices that offer minimally invasive and precise methods for stone removal. Technologies such as laser lithotripters and advanced endoscopic tools have revolutionized treatment options, attracting both patients and healthcare professionals.
Advancements in Medical Technology
Advancements in medical technology have led to the development of minimally invasive treatment options for urolithiasis. These innovations are transforming the way healthcare providers manage kidney stones. Techniques such as laser lithotripsy and advanced endoscopic tools allow for precise and less invasive methods of stone removal. Patients are increasingly seeking these treatments due to their effectiveness and the reduced discomfort and recovery times they offer.
Rising Awareness and Education
Increasing awareness and education about urolithiasis have contributed significantly to the growth of urolithiasis management devices. When individuals are informed about the causes, symptoms, and potential complications of kidney stones, they are more likely to seek medical attention and early diagnosis. This, in turn, creates a heightened demand for management devices as patients and healthcare providers prioritize early intervention.
Patient Experience and Expectations
Patients today are seeking healthcare experiences that are centered around their needs and preferences. This shift towards patient-centered care has driven the development of urolithiasis management devices that prioritize patient experience. These devices offer less invasive procedures, reduced pain, and quicker recovery times, aligning with patient expectations for comfort and convenience.
Patients anticipate safe and effective treatments with minimal complications. Urolithiasis management devices that meet these expectations not only enhance patient satisfaction but also encourage the adoption of these devices by healthcare providers and medical facilities.
Key Market Challenges
High Treatment Costs
Urolithiasis, or kidney stone disease, can indeed impose substantial financial strain, especially in instances necessitating surgical interventions. The expenses associated with urolithiasis management devices, surgical procedures, hospitalization, and post-operative care can accumulate, posing a significant financial burden on patients and healthcare systems alike. The costs may encompass expenses related to diagnostic imaging, such as CT scans or ultrasounds, as well as surgical procedures like ureteroscopy, extracorporeal shock wave lithotripsy (ESWL), or percutaneous nephrolithotomy (PCNL).Hospital stays and follow-up consultations contribute to the overall expenditure. Affordability thus emerges as a pressing concern for individuals seeking treatment and healthcare providers endeavoring to deliver comprehensive care while managing costs effectively. Efforts to mitigate this financial burden may involve the development of cost-effective urolithiasis management devices, the adoption of minimally invasive techniques to reduce surgical expenses, and the implementation of strategies to streamline post-operative care. By addressing affordability concerns, stakeholders in the urolithiasis management sector can enhance access to quality care and alleviate the financial strain experienced by patients and healthcare systems.
Limited Access to Advanced Technology
Access to cutting-edge urolithiasis management devices and technology varies significantly across different regions and healthcare systems. While some regions and medical facilities may have access to the latest treatment options and state-of-the-art devices, others, particularly underserved areas, may face limitations in accessing such advanced resources. This discrepancy in access to urolithiasis management technology can lead to disparities in healthcare outcomes, with patients in underserved areas potentially experiencing delayed diagnosis, suboptimal treatment, and poorer prognoses compared to those in regions with better access to advanced medical care.
Key Market Trends
Innovative Urolithiasis Devices
Innovative urolithiasis devices are revolutionizing the landscape of urolithiasis management, offering advanced solutions for the diagnosis, treatment, and prevention of kidney stone disease. These devices encompass a wide range of technologies and approaches, including minimally invasive surgical instruments, lithotripsy devices, ureteral stents, and imaging modalities such as advanced endoscopic and ultrasound techniques.
Data-Driven Care
Data-driven approaches are increasingly influencing urolithiasis management. The collection and analysis of data related to patient outcomes, treatment efficacy, and preventive measures are guiding healthcare decisions. This data-centric approach is valuable for improving the quality of care and enhancing research and development efforts.
Patient-Centered Care
Data-driven care is revolutionizing urolithiasis management by harnessing the power of data analytics and technology to optimize patient outcomes. Through the collection and analysis of vast amounts of patient data, healthcare providers can gain valuable insights into patterns, trends, and risk factors associated with kidney stone disease. This data-driven approach enables personalized treatment plans tailored to each patient's unique characteristics and medical history, leading to more effective and efficient care. D
Segmental Insights
Treatment Type Insights
Based on Treatment Type, the intracorporeal lithotripsy sector emerged as the dominant force in the market, claiming the largest portion of revenue in 2023. It is poised to exhibit the most rapid CAGR throughout the projected period. Intracorporeal lithotripsy entails the use of an endoscope to visualize stones and simultaneously disintegrate them into manageable fragments using laser technology. This method is typically employed for patients with large stones who are not suitable candidates for Extracorporeal Shock Wave Lithotripsy (ESWL). Intracorporeal lithotripsy treatments boast an impressive stone-free success rate of nearly 95% and involve minimal implantation. These procedures, performed under anesthesia, are readily accessible in medical facilities worldwide. Despite being an invasive approach, intracorporeal lithotripsy delivers remarkable stone-free outcomes, requires less time than ESWL, and is associated with minimal to no apparent side effects. Consequently, it is expected to become the preferred method for stone removal in the foreseeable future.
Conversely, in 2023, the ESWL segment secured a significant share of the revenue. ESWL remains a widely used, minimally invasive treatment due to its accessibility and cost-effectiveness. This technique primarily employs shock waves to break down stones with diameters ranging from 4 mm to 2 cm into smaller pieces, facilitating their passage from the body. Typically, ESWL is conducted on an outpatient basis, eliminating the need for a hospital stay. It is particularly effective for relatively smaller urinary stones, which are prevalent among stone-afflicted patients. The shock wave generators employed in this method include electrohydraulic, piezoelectric, and electromagnetic devices.
End Use Insights
Based on end use, the "Hospitals & Clinics" sector secured a substantial share of revenue in 2023, attributed to hospitals' investments in expanding their surgical infrastructure, the rise in kidney stone treatments conducted within hospital settings, and the establishment of new hospitals in various regions. The segment's growth is significantly influenced by the favorable reimbursement policies provided by hospitals.
On the other hand, the "Ambulatory Surgical Centers (ASCs)" category is anticipated to experience the most rapid CAGR throughout the projected period. When dealing with large obstructive urinary stones, surgical removal becomes a necessary option. Ambulatory surgical centers are gradually gaining popularity due to their time-saving and cost-effective treatment alternatives, which reduce extended hospital stays. Technological advancements in the field of surgery, including the availability of minimally invasive tools such as endoscopes and precision instruments, enable urologists to carry out painless stone removal procedures. The preference for ambulatory surgical centers for treating urinary stones is expected to be notably higher in developed countries like the United States, Canada, the United Kingdom, and Germany, primarily because of their convenient accessibility.
Regional Insights
Based on region, North America emerged as the dominant force in the market, capturing the largest share of revenue. This can be attributed to various factors, including the increasing incidence of stone formations leading to urolithiasis, a heightened risk of end-stage renal disease within the population, and the continual approval of new products, all of which are expected to be key drivers of market growth. According to the 2021 guidelines from the Canadian Urological Association, nephrolithiasis affects approximately 10-12% of men and 7-8% of women worldwide, with a gradual increase in urolithiasis prevalence, despite some regional variations. As per data from the Centers for Disease Control and Prevention (CDC), kidney disorders rank prominently among the causes of death in the United States. A significant portion of the 37 million adults with chronic kidney disease (CKD) in the U.S. remains undiagnosed. The region is witnessing an expanding awareness among the patient population regarding the availability of new treatment options for stone-related ailments, alongside the accessibility of medical devices, further fueling market growth in North America.
Conversely, the Asia Pacific region is anticipated to experience the swiftest CAGR over the forecast period. The prevalence of kidney stones in this region is on the rise due to a combination of factors, including shifts in dietary patterns, lifestyle changes, and variations in climate. As indicated by data from the National Center for Biotechnology Information (NCBI), it is projected that the prevalence of kidney stones will reach 14.3% in China and 12.7% in India by the year 2030. The healthcare expenditure in the region is undergoing rapid expansion, driven by increased awareness among governments and individuals about the significance of good health. This is, in turn, bolstering the market, as patients are more inclined to seek treatment for kidney stones in response to these developments.
Recent Developments
- In July 2022, Calyxo, a company specializing intechnology for non-surgical kidney stone removal, announced the successfulclosure of its Series C investment round, raising a total of $32.7 million.This California-based company, Calyxo, developed the CVAC Aspiration system,with the objective of eliminating kidney stones without the need for surgery.This innovative system employs a combination of irrigation and aspirationtechniques to achieve this.
- In January 2022, the FDA granted breakthroughdesignation to Applaud Medical's Acoustic Enhancer technology, as per anofficial statement. San Francisco-based Applaud Medical introduced thisAcoustic Enhancer technology, designed for use alongside ureteroscopy withlaser lithotripsy (URS-LL) for the fragmentation of calcium-based urinarystones that cause obstruction or are deemed to pose a significant risk offuture complications by urologists or other qualified medical professionals.These stones should be between 6mm and 20mm in diameter.
- Likewise in March 2021, Boston Scientific and aunit of Baring Private Equity Asia (BPEA) entered into a binding agreement,with Boston Scientific agreeing to make an upfront cash payment of $1.07billion to acquire Lumenis' global surgical business. This strategicacquisition enabled Boston Scientific to expand its global portfolio of kidneystone management products.
- In June 2020, Olympus Corporation introduced theSoltive Laser System, a novel thulium fiber laser application specificallydesigned for soft tissue procedures and stone lithotripsy.
Key Market Players
- Allengers Medical Systems Ltd
- BostonScientific Corp
- CookMedical Inc
- CONMEDCorp
- DiREXGroup
- DornierMedTech GmbH
- HealthTronicsInc
- KarlStorz SE & Co KG
- LumenisInc
- SiemensHealthcare Ltd
| By Treatment Type | By End Use | By Region |
|
|
|
FAQ'S
For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:
Within 24 to 48 hrs.
You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email
You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.
Discounts are available.
Hard Copy